Review



3d diode array arccheck phantom model 1220  (Sun Nuclear Corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Sun Nuclear Corporation 3d diode array arccheck phantom model 1220
    Percentage dosimetric differences between treatment planning system (TPS) vs M3D, TPS vs MFX, and TPS vs <t> ArcCHECK </t> for head‐and‐neck cancer patients.
    3d Diode Array Arccheck Phantom Model 1220, supplied by Sun Nuclear Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3d+diode+array+arccheck+phantom+model+1220/3d+diode+array+arccheck/pmc07700942-120-8-15
    Average 90 stars, based on 1 article reviews
    3d diode array arccheck phantom model 1220 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Cross verification of independent dose recalculation, log files based, and phantom measurement‐based pretreatment quality assurance for volumetric modulated arc therapy"

    Article Title: Cross verification of independent dose recalculation, log files based, and phantom measurement‐based pretreatment quality assurance for volumetric modulated arc therapy

    Journal: Journal of Applied Clinical Medical Physics

    doi: 10.1002/acm2.13036

    Percentage dosimetric differences between treatment planning system (TPS) vs M3D, TPS vs MFX, and TPS vs ArcCHECK for head‐and‐neck cancer patients.
    Figure Legend Snippet: Percentage dosimetric differences between treatment planning system (TPS) vs M3D, TPS vs MFX, and TPS vs ArcCHECK for head‐and‐neck cancer patients.

    Techniques Used:

    Percentage dosimetric differences between TPS vs M3D, TPS vs MFX, and TPS vs ArcCHECK for chest cancer patients.
    Figure Legend Snippet: Percentage dosimetric differences between TPS vs M3D, TPS vs MFX, and TPS vs ArcCHECK for chest cancer patients.

    Techniques Used:

    Percentage dosimetric differences between TPS vsM3D, TPS vs MFX, and TPS vs ArcCHECK for abdomen cancer patients.
    Figure Legend Snippet: Percentage dosimetric differences between TPS vsM3D, TPS vs MFX, and TPS vs ArcCHECK for abdomen cancer patients.

    Techniques Used:

    Percentage gamma pass rates of individual volume gamma indices and global gamma indices for three sites patients at 3%/3 mm criterion.
    Figure Legend Snippet: Percentage gamma pass rates of individual volume gamma indices and global gamma indices for three sites patients at 3%/3 mm criterion.

    Techniques Used:

    Related Articles

    other:

    Article Title: Cross verification of independent dose recalculation, log files based, and phantom measurement‐based pretreatment quality assurance for volumetric modulated arc therapy
    Article Snippet: Phantom measurement‐based QA was carried out by a 3D diode array ArcCHECK phantom (Model 1220; Sun Nuclear Corporation, USA).



    Similar Products

    3d diode array arccheck phantom model 1220  (Sun Nuclear Corporation)
    90
    Sun Nuclear Corporation 3d diode array arccheck phantom model 1220
    Percentage dosimetric differences between treatment planning system (TPS) vs M3D, TPS vs MFX, and TPS vs <t> ArcCHECK </t> for head‐and‐neck cancer patients.
    3d Diode Array Arccheck Phantom Model 1220, supplied by Sun Nuclear Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3d+diode+array+arccheck+phantom+model+1220/3d+diode+array+arccheck/pmc07700942-120-8-15
    Average 90 stars, based on 1 article reviews
    3d diode array arccheck phantom model 1220 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Percentage dosimetric differences between treatment planning system (TPS) vs M3D, TPS vs MFX, and TPS vs ArcCHECK for head‐and‐neck cancer patients.

    Journal: Journal of Applied Clinical Medical Physics

    Article Title: Cross verification of independent dose recalculation, log files based, and phantom measurement‐based pretreatment quality assurance for volumetric modulated arc therapy

    doi: 10.1002/acm2.13036

    Figure Lengend Snippet: Percentage dosimetric differences between treatment planning system (TPS) vs M3D, TPS vs MFX, and TPS vs ArcCHECK for head‐and‐neck cancer patients.

    Article Snippet: Phantom measurement‐based QA was carried out by a 3D diode array ArcCHECK phantom (Model 1220; Sun Nuclear Corporation, USA).

    Techniques:

    Percentage dosimetric differences between TPS vs M3D, TPS vs MFX, and TPS vs ArcCHECK for chest cancer patients.

    Journal: Journal of Applied Clinical Medical Physics

    Article Title: Cross verification of independent dose recalculation, log files based, and phantom measurement‐based pretreatment quality assurance for volumetric modulated arc therapy

    doi: 10.1002/acm2.13036

    Figure Lengend Snippet: Percentage dosimetric differences between TPS vs M3D, TPS vs MFX, and TPS vs ArcCHECK for chest cancer patients.

    Article Snippet: Phantom measurement‐based QA was carried out by a 3D diode array ArcCHECK phantom (Model 1220; Sun Nuclear Corporation, USA).

    Techniques:

    Percentage dosimetric differences between TPS vsM3D, TPS vs MFX, and TPS vs ArcCHECK for abdomen cancer patients.

    Journal: Journal of Applied Clinical Medical Physics

    Article Title: Cross verification of independent dose recalculation, log files based, and phantom measurement‐based pretreatment quality assurance for volumetric modulated arc therapy

    doi: 10.1002/acm2.13036

    Figure Lengend Snippet: Percentage dosimetric differences between TPS vsM3D, TPS vs MFX, and TPS vs ArcCHECK for abdomen cancer patients.

    Article Snippet: Phantom measurement‐based QA was carried out by a 3D diode array ArcCHECK phantom (Model 1220; Sun Nuclear Corporation, USA).

    Techniques:

    Percentage gamma pass rates of individual volume gamma indices and global gamma indices for three sites patients at 3%/3 mm criterion.

    Journal: Journal of Applied Clinical Medical Physics

    Article Title: Cross verification of independent dose recalculation, log files based, and phantom measurement‐based pretreatment quality assurance for volumetric modulated arc therapy

    doi: 10.1002/acm2.13036

    Figure Lengend Snippet: Percentage gamma pass rates of individual volume gamma indices and global gamma indices for three sites patients at 3%/3 mm criterion.

    Article Snippet: Phantom measurement‐based QA was carried out by a 3D diode array ArcCHECK phantom (Model 1220; Sun Nuclear Corporation, USA).

    Techniques: